Imunon, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMNN research report →
Companywww.imunon.com
Imunon, Inc. , a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications.
- CEO
- Stacy R. Lindborg
- IPO
- 1999
- Employees
- 25
- HQ
- Lawrenceville, NJ, US
Price Chart
Valuation
- Market Cap
- $5.37M
- P/E
- -0.73
- P/S
- 0.00
- P/B
- 3.19
- EV/EBITDA
- -0.11
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -341.23%
- ROIC
- -346.77%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-14,495,000 · 22.15%
- EPS
- $-6.83 · 67.63%
- Op Income
- $-14,650,694
- FCF YoY
- 24.93%
Performance & Tape
- 52W High
- $41.22
- 52W Low
- $2.08
- 50D MA
- $2.88
- 200D MA
- $4.09
- Beta
- 2.03
- Avg Volume
- 90.91K
Get TickerSpark's AI analysis on IMNN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 15, 26 | CHURCH JEFFREY WAYNE | other | 0 |
| Jan 2, 26 | CHURCH JEFFREY WAYNE | other | 5,000 |
| Aug 4, 25 | CHURCH JEFFREY WAYNE | other | 167 |
| Jan 2, 26 | Bragg Kimberly | other | 9,050 |
| Jan 2, 26 | Anwer Khursheed | other | 15,736 |
| Jan 2, 26 | Fritz Frederick J. | other | 5,892 |
| Jan 2, 26 | Faller Douglas Vincent | other | 12,667 |
| Jan 2, 26 | Eylward Susan | other | 8,251 |
| Jan 2, 26 | Pellizzari Christine A | other | 4,827 |
| Jan 2, 26 | Braun Donald P | other | 5,881 |
Our IMNN Coverage
We haven't published any research on IMNN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IMNN Report →